Announcements Trials
Browse Landscape

Status

Completed 17Recruiting 8Terminated 4Active not recruiting 3No longer available 2Unknown 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Expanded_access 2

Sponsor

Cancer Type

CNS 7Dermatologic 2Sarcoma 1Gastrointestinal 1

Conditions

Melanoma 16Lymphoma, T-Cell, Cutaneous 2Glioma 2Glioblastoma 2Uveal Melanoma 1Skin Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma 1Liver Neoplasms 1Keratosis 1Hodgkin Disease 1Hematologic Diseases 1Cutaneous or Subcutaneous Tumors Where There is no Comparable or Satisfactory 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Basal Cell 1Carcinoma 1Breast Neoplasms 1Bowen's Disease 1

Interventions

pembrolizumab 1efineptakin alfa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
No longer available × Glioma × Dermatologic × Clear all
NCT04289155 2022-03-17

Individual Patient Compassionate Use of GX-I7

Genexine, Inc.

No longer available
CNSDermatologic

Glioblastoma, Glioma, Melanoma

NCT03311542 2018-01-10

Expanded Access for Pembrolizumab (MK-3475)

Center Trials & Treatment

No longer available
CNSDermatologic

Glioblastoma, Glioma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡